Many people with HIV have long-lasting pain that is hard to treat. Often, strong medicines called opioids are used but they have bad side effects. This study will test a different medicine called Low Dose Naltrexone (LDN). Naltrexone is usually used for people with alcohol or drug problems, but at a lower dose, it might help with pain. The study will have 40 people with HIV take LDN for 12 weeks to see if it helps their pain and improves their immune system.
Key Points to Consider:
- The study lasts for 12 weeks.
- Participants will need to visit the study site regularly.
- LDN may help reduce pain and improve overall health.
To join, you need to be 18-65 years old, have HIV with controlled virus levels, and experience nerve-related pain. You cannot join if you are pregnant, using opioids, or have certain health problems like liver disease or mental health issues. This study hopes to find a safer way to manage pain for people living with HIV.